Riten Kumar, Director, Thrombosis and Anticoagulation Program at Boston Children’s Hospital, shared on LinkedIn:
“Direct oral anticoagulants are efficacious when appropriately used in children with cancer associated thrombosis – though the rate of clinically relevant bleeding in this cohort was higher than what’s been reported in the pediatric randomized trials.
Most CRNM bleeds occurred in the setting of thrombocytopenia.”
Other articles featuring Pediatric Oncology.